The FDA approved the emergency use of the Sinopharm COVID-19 vaccine in the Philippines.
The Food and Drug Administration (FDA) recently approved the emergency use of the Sinopharm COVID-19 vaccine in the Philippines.
This, as the COVID-19 vaccine developed by Sinopharm was the 8th vaccine to be granted emergency use authorization (EUA) in the Philippines, next to Pfizer-BioNTech, AstraZeneca-Oxford, Sinovac’s CoronaVac, India’s Bharat Biotech, Johnson & Johnson’s Janssen Pharmaceuticals, Gamaleya’s Sputnik V, and Moderna COVID-19 vaccines.
According to FDA Director-General Eric Domingo, the agency’s experts had reviewed Sinopharm’s application and its application was approved on Monday.
In early May, the World Health Organization (WHO) approved the said vaccine for emergency use. The said vaccine was the first Chinese vaccine to receive the WHO’s green light.
The UN health agency signed off on the said vaccine, which was already being deployed in some countries around the world.
The WHO had already given an emergency use listing (EUL) to COVID-19 vaccines being made by Pfizer-BioNTech, AstraZeneca-Oxford, Moderna, Janssen Pharmaceuticals, and Sinovac
According to the Department of Health (DOH), the Sinopharm COVID-19 vaccine underwent the usual regulatory process despite its emergency use listing from the WHO.
Health Secretary Francisco Duque III had since ordered the filing for an emergency use authorization with the FDA for donated Sinopharm COVID-19 vaccine doses.
What can you say about this? Let us know in the comments below.